Log in to your IBTimes Account

close
ID
Password
  • Set your IBTimes.com Edition

U.S. biotech industry awaits Europe approval speedup



By Missy Ryan
02 August 2007 @ 10:34 am ET

Related Topic

Get stories by e-mail on this topic.

  • biotechnology europe | RSS
E-mail:

Bomer said the case is important not only because other countries may look to Europe for guidance on biotech regulation, but also because the bloc's "zero-tolerance" approach on unapproved products has the potential to derail massive trade flows from nations with more permissive systems.

"It has a tremendous impact on billions of dollars worth of trade when our approval systems are so disparate," she said.

A recent internal report last month said the EU took at least 2-1/2 years, and often much longer, to complete new GMO authorizations, compared with 15 months in the United States.

The issue rankles some in Washington. Last fall, a group of lawmakers pressed U.S. Trade Representative Susan Schwab to do more to force compliance from Europe.

Schwab's office declined comment on what steps the United States would take if it deems that Europe still falls short.

Copyright 2009 Thomson Reuters. All rights reserved.

    Click!
  • Rate this article:

Comments

Post Your Comment

*Name


advertisement
More Politics & Policy
After a landmark win in the House of Representatives, President Barack Obama's push for healthcare reform faces a difficult path in the Senate amid divis...
Software, biotech firms and others who develop new ways to do business will be watching closely on Monday as the U.S. Supreme Court hears a case that cou...
U.S. President Barack Obama urged Americans on Friday not to jump to conclusions on the motive behind the mass shooting at the sprawling Fort Hood army b...

advertisement
Advertisement
POS Magnetic Card Readers

Online distributor for point of sale equipment, TYSSO and Pegasus.

 
IBTimes.com Web
Partners
International Business Times© 2009 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives